Chronic myeloid leukemia

Indexed in Crossref

8 abstracts matching chronic myeloid leukemia from the meeting's journal supplement, fetched live from Crossref 2026-11-12 08:04 UTC. This is a keyword search, not the complete abstract book.

• 6830
  State-transition model of time-series single-cell RNA-seq identifies gene-level origins of disease microstate stability in chronic myeloid leukemia (CML).

  David Eugene Frankhouser, Anupam Dey, Jennifer Rangel Ambriz, Ziang Chen et al.
• 6499
  Targeting BCR-ABL1-independent mechanisms of resistance in chronic myeloid leukemia

  Mark Pusung, Christopher A. Eide, Jessica Gibbs, Daniel Bottomly et al.
• 3028
  Investigating phosphatidylcholine and phosphoethanolamine phospholipids in conventional and novel cationic nanoliposomes for interactions with chronic myeloid leukemia cells in vitro

  Shivmani Y. Barve, Robert B. Campbell
• 6655
  Characterization of adverse cutaneous effects in the setting of ponatinib, bosutinib, andasciminib for chronic myeloid leukemia patients.

  Ruhi Kanwar, Juna Khang, Goranit Sakunchotpanit, Ruhi Nayak et al.
• 5917
  Single-cell profiling of NK cells in chronic myeloid leukemia identifies distinct cell states with gene regulatory signatures associated with differential outcomes after imatinib discontinuation

  Santoshi Borra, Da Yan, Robert S. Welner, Zongliang Yue
• 3108
  LEDGF/p75 drives chemoresistance in CML via JAK/STAT pathway modulation

  Thatcher Akele, Cecilia Iglesias-Herrero, Frauke Christ, Zeger Debyser
• LB181
  Quantitative deep mutational scanning (qDMS) enables accurate predictions of clinical drug resistance in CML

  Marta Tomaszkiewicz, Simon Beardsley, Justin Pritchard, Joshua Reynolds
• 4186
  A novel integrated AI ML and COSMIC signature profiling approach resolving blast crisis CML heterogeneity into single patient level pan cancer actionable programs enabling repurposable therapies for relapsed refractory and metastasized cancers

  Zafar Iqbal, Abdulkareem AlGarni, Lubna Alnuaim, Sahrish Khan et al.